FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575634747> ?p ?o ?g. }

• W2575634747 endingPage "1297" @default.
• W2575634747 startingPage "1287" @default.
• W2575634747 abstract "Aim The objectives of this study were to characterize age‐related changes in lamivudine pharmacokinetics in children and evaluate lamivudine exposure, followed by dose recommendations for subgroups in which target steady state area under the daily plasma concentration–time curve (AUC 0–24h ) is not reached. Methods Population pharmacokinetic modelling was performed in NONMEM using data from two model‐building datasets and two external datasets [ n = 180 (age 0.4–18 years, body weight 3.4–60.5 kg); 2061 samples (median 12 per child); daily oral dose 60–300 mg (3.9–17.6 mg kg –1 )]. Steady state AUC 0–24h was calculated per individual (adult target 8.9 mg·h l –1 ). Results A two‐compartment model with sequential zero order and first order absorption best described the data. Apparent clearance and central volume of distribution (% RSE) were 13.2 l h –1 (4.2%) and 38.9 l (7.0%) for a median individual of 16.6 kg, respectively. Bodyweight was identified as covariate on apparent clearance and volume of distribution using power functions (exponents 0.506 (20.2%) and 0.489 (32.3%), respectively). The external evaluation supported the predictive ability of the final model. In 94.5% and 35.8% of the children with a body weight >14 kg and <14 kg, respectively, the target AUC 0–24h was reached. Conclusion Bodyweight best predicted the developmental changes in apparent lamivudine clearance and volume of distribution. For children aged 5 months–18 years with a body weight <14 kg, the dose should be increased from 8 to 10 mg kg –1 day –1 if the adult target for AUC 0–24h is aimed for. In order to identify whether bodyweight influences bioavailability, clearance and/or volume of distribution, future analysis including data on intravenously administered lamivudine is needed." @default.
• W2575634747 created "2017-01-26" @default.
• W2575634747 creator A5021568119 @default.
• W2575634747 creator A5026079355 @default.
• W2575634747 creator A5031474875 @default.
• W2575634747 creator A5057611366 @default.
• W2575634747 creator A5062804930 @default.
• W2575634747 creator A5064245613 @default.
• W2575634747 creator A5085233896 @default.
• W2575634747 creator A5091414507 @default.
• W2575634747 date "2017-02-14" @default.
• W2575634747 modified "2023-10-17" @default.
• W2575634747 title "Dose evaluation of lamivudine in human immunodeficiency virus-infected children aged 5 months to 18 years based on a population pharmacokinetic analysis" @default.
• W2575634747 cites W105671925 @default.
• W2575634747 cites W135147496 @default.
• W2575634747 cites W1517608807 @default.
• W2575634747 cites W1517653170 @default.
• W2575634747 cites W1539567812 @default.
• W2575634747 cites W1599520248 @default.
• W2575634747 cites W1965479467 @default.
• W2575634747 cites W1970580273 @default.
• W2575634747 cites W1975735670 @default.
• W2575634747 cites W1998204576 @default.
• W2575634747 cites W1999521622 @default.
• W2575634747 cites W2005617325 @default.
• W2575634747 cites W2006583270 @default.
• W2575634747 cites W2016761119 @default.
• W2575634747 cites W2023203133 @default.
• W2575634747 cites W2032186554 @default.
• W2575634747 cites W2033419567 @default.
• W2575634747 cites W2036611705 @default.
• W2575634747 cites W2037267416 @default.
• W2575634747 cites W2044403944 @default.
• W2575634747 cites W2049319389 @default.
• W2575634747 cites W2050942818 @default.
• W2575634747 cites W2054937433 @default.
• W2575634747 cites W2064111789 @default.
• W2575634747 cites W2068616720 @default.
• W2575634747 cites W2095273553 @default.
• W2575634747 cites W2099137035 @default.
• W2575634747 cites W2106587562 @default.
• W2575634747 cites W2108962146 @default.
• W2575634747 cites W2109757270 @default.
• W2575634747 cites W2112606698 @default.
• W2575634747 cites W2120725688 @default.
• W2575634747 cites W2121276534 @default.
• W2575634747 cites W2133210936 @default.
• W2575634747 cites W2141400171 @default.
• W2575634747 cites W2145341868 @default.
• W2575634747 cites W2156226084 @default.
• W2575634747 cites W2159764323 @default.
• W2575634747 cites W2162984747 @default.
• W2575634747 cites W2167617927 @default.
• W2575634747 cites W2194756172 @default.
• W2575634747 cites W2404715942 @default.
• W2575634747 cites W4319053868 @default.
• W2575634747 doi "https://doi.org/10.1111/bcp.13227" @default.
• W2575634747 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5427247" @default.
• W2575634747 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28079918" @default.
• W2575634747 hasPublicationYear "2017" @default.
• W2575634747 type Work @default.
• W2575634747 sameAs 2575634747 @default.
• W2575634747 citedByCount "7" @default.
• W2575634747 countsByYear W25756347472017 @default.
• W2575634747 countsByYear W25756347472018 @default.
• W2575634747 countsByYear W25756347472019 @default.
• W2575634747 countsByYear W25756347472021 @default.
• W2575634747 countsByYear W25756347472022 @default.
• W2575634747 crossrefType "journal-article" @default.
• W2575634747 hasAuthorship W2575634747A5021568119 @default.
• W2575634747 hasAuthorship W2575634747A5026079355 @default.
• W2575634747 hasAuthorship W2575634747A5031474875 @default.
• W2575634747 hasAuthorship W2575634747A5057611366 @default.
• W2575634747 hasAuthorship W2575634747A5062804930 @default.
• W2575634747 hasAuthorship W2575634747A5064245613 @default.
• W2575634747 hasAuthorship W2575634747A5085233896 @default.
• W2575634747 hasAuthorship W2575634747A5091414507 @default.
• W2575634747 hasBestOaLocation W25756347471 @default.
• W2575634747 hasConcept C112705442 @default.
• W2575634747 hasConcept C126322002 @default.
• W2575634747 hasConcept C139254425 @default.
• W2575634747 hasConcept C140793950 @default.
• W2575634747 hasConcept C147583825 @default.
• W2575634747 hasConcept C203014093 @default.
• W2575634747 hasConcept C2522874641 @default.
• W2575634747 hasConcept C2776239304 @default.
• W2575634747 hasConcept C2777869810 @default.
• W2575634747 hasConcept C2780593183 @default.
• W2575634747 hasConcept C2908647359 @default.
• W2575634747 hasConcept C3020755252 @default.
• W2575634747 hasConcept C71924100 @default.
• W2575634747 hasConcept C76318530 @default.
• W2575634747 hasConcept C86803240 @default.
• W2575634747 hasConcept C90924648 @default.
• W2575634747 hasConcept C99454951 @default.
• W2575634747 hasConceptScore W2575634747C112705442 @default.
• W2575634747 hasConceptScore W2575634747C126322002 @default.
• W2575634747 hasConceptScore W2575634747C139254425 @default.

• next